Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development

cafead

Administrator
Staff member
  • cafead   Oct 06, 2021 at 10:52: AM
via Dynavax will conduct a Phase 2 clinical trial combining the US Department of Defense’ rF1V vaccine with its CpG 1018 adjuvant.

article source